We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

67 hedge funds and large institutions have $170M invested in Minerva Neurosciences in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

0.7% more ownership

Funds ownership: 8.38% → 9.08% (+0.7%)

4% less funds holding

Funds holding: 70 → 67 (-3)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

22% less capital invested

Capital invested by funds: $217M → $170M (-$46.7M)

Holders
67
Holders Change
-3
Holders Change %
-4.29%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
21
Reduced
19
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$1.67M
2
HCMT
Highland Capital Management (Texas)
Texas
+$1.38M
3
SFM
Sphera Funds Management
Israel
+$930K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$403K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$336K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.08M
2
NC
Nexthera Capital
New York
-$4.08M
3
JGC
J. Goldman & Co
New York
-$1.19M
4
NFA
Nationwide Fund Advisors
Ohio
-$950K
5
Renaissance Technologies
Renaissance Technologies
New York
-$858K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$406K -$858K -17,312 -67%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$393K +$403K +8,125 New
Morgan Stanley
28
Morgan Stanley
New York
$350K +$109K +2,203 +44%
Swiss National Bank
29
Swiss National Bank
Switzerland
$311K – – –
TA
30
Teachers Advisors
New York
$307K +$29.7K +599 +10%
TD Asset Management
31
TD Asset Management
Ontario, Canada
$301K -$1.88K -38 -0.6%
Charles Schwab
32
Charles Schwab
California
$287K -$60.1K -1,212 -17%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$279K -$6.2K -125 -2%
AllianceBernstein
34
AllianceBernstein
Tennessee
$266K +$14.9K +300 +6%
AA
35
ALPS Advisors
Colorado
$259K +$6.35K +128 +2%
Goldman Sachs
36
Goldman Sachs
New York
$247K +$81.8K +1,649 +48%
TI
37
Trexquant Investment
Connecticut
$169K +$19.1K +385 +12%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$155K – – –
Squarepoint
39
Squarepoint
New York
$154K +$157K +3,172 New
ProShare Advisors
40
ProShare Advisors
Maryland
$150K -$7.19K -145 -4%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$141K -$27.5K -554 -16%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$141K -$11.1K -224 -7%
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$137K +$141K +2,838 New
AIMCA
44
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$133K – – –
UBS AM
45
UBS AM
Illinois
$123K – – –
AWCI
46
Alpine Woods Capital Investors
New York
$121K – – –
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$109K – – –
AIG
48
American International Group
New York
$108K +$6.2K +125 +6%
PP
49
Paloma Partners
Connecticut
$92K +$94.2K +1,900 New
CS
50
Credit Suisse
Switzerland
$79K -$72K -1,453 -47%
1
2
3 4

NERV Hedge Fund Activity: Q4 2017 in Review

67 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2017, worth a combined $170M — down 22% from $217M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of NERV and 11 opened new positions — a net loss of 3 holders — while 19 trimmed existing stakes and 21 added.

The largest buyer was JP Morgan Chase, adding an estimated $1.67M. The largest seller was Fidelity Investments, cutting an estimated $6.08M.

  • 67 institutional investors held Minerva Neurosciences (NERV) as of Q4 2017, down from 70 in Q3 2017.
  • Funds reported $170M of Minerva Neurosciences stock for Q4 2017, down 22% quarter-over-quarter.
  • 11 funds opened new Minerva Neurosciences positions in Q4 2017 and 14 closed out, a net change of -3 holders.
  • The largest Minerva Neurosciences buyer in Q4 2017 was JP Morgan Chase, an estimated $1.67M added.
  • The largest Minerva Neurosciences seller in Q4 2017 was Fidelity Investments, an estimated $6.08M sold.

Based on aggregated 13F filings for Q4 2017.